Literature DB >> 18222490

Abolishment of TNBS-induced visceral hypersensitivity in mast cell deficient rats.

Katsuyo Ohashi1, Yasushi Sato, Mitsuhisa Kawai, Yoichi Kurebayashi.   

Abstract

Mucosal mast cells are implicated in visceral hypersensitivity associated with irritable bowel syndrome (IBS). In this study, we investigated the role of mast cells in the development of visceral hypersensitivity by using mast cell deficient (Ws/Ws) rats and their control (W+/W+). In W+/W+ rats, an injection of 2,4,6-trinitrobenzene sulfonic acid (TNBS) into the proximal colon produced a significant decrease in pain threshold of the distal colon. Severe mucosal necrosis and inflammatory cell infiltration with concomitant increase in tissue myeloperoxidase activity were observed in the proximal colon that was directly insulted by TNBS, whereas neither necrosis nor increased myeloperoxidase activity occurred in the distal colon, indicating that TNBS-induced hypersensitivity is not caused by the local tissue damage or inflammation in the region of the gut where distention stimuli were applied. On the other hand, TNBS failed to elicit visceral hypersensitivity in Ws/Ws rats. This finding indicates that mast cells are essential for development of TNBS-induced visceral hypersensitivity in rats. Since the severity of TNBS-induced proximal colon injury and MPO activity was not affected by mast cell deficiency, it is unlikely that abolishment of visceral hypersensitivity in mast cell deficient rats was a result of altered development of the primary injury in the proximal colon. There was no difference between sham-operated Ws/Ws and W+/W+ rats in colonic pain threshold to distention stimuli, indicating that mast cells play no modulatory roles in normal colonic nociception. The present results support the view that mucosal mast cells play key roles in the pathogenesis of IBS.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18222490     DOI: 10.1016/j.lfs.2007.11.027

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  12 in total

1.  Mast cell degranulation distinctly activates trigemino-cervical and lumbosacral pain pathways and elicits widespread tactile pain hypersensitivity.

Authors:  Dan Levy; Vanessa Kainz; Rami Burstein; Andrew M Strassman
Journal:  Brain Behav Immun       Date:  2011-10-12       Impact factor: 7.217

Review 2.  Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions.

Authors:  Lena Ohman; Magnus Simrén
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-01-26       Impact factor: 46.802

3.  Irritable bowel syndrome and inflammatory bowel disease: infectious gastroenteritis-related disorders?

Authors:  Shunji Ishihara; Monowar Aziz; Naoki Oshima; Yoshiyuki Mishima; Hiroshi Imaoka; Ichiro Moriyama; Yoshikazu Kinoshita
Journal:  Clin J Gastroenterol       Date:  2009-01-06

Review 4.  Neuroanatomy of lower gastrointestinal pain disorders.

Authors:  Wim Vermeulen; Joris G De Man; Paul A Pelckmans; Benedicte Y De Winter
Journal:  World J Gastroenterol       Date:  2014-01-28       Impact factor: 5.742

Review 5.  Nerve growth factor and diarrhea-predominant irritable bowel syndrome (IBS-D): a potential therapeutic target?

Authors:  Xiao-juan Xu; Liang Liu; Shu-kun Yao
Journal:  J Zhejiang Univ Sci B       Date:  2016-01       Impact factor: 3.066

6.  Mast cell stabilizer ketotifen fumarate reverses inflammatory but not neuropathic-induced mechanical pain in mice.

Authors:  Carolina B Meloto; Pablo Ingelmo; Eduardo Vega Perez; Rebecca Pitt; Víctor Hugo González Cárdenas; Nada Mohamed; Susana G Sotocinal; Valerie Bourassa; Lucas Vasconcelos Lima; Alfredo Ribeiro-da-Silva; Jeffrey S Mogil; Luda Diatchenko
Journal:  Pain Rep       Date:  2021-06-03

7.  Central nervous system mast cells in peripheral inflammatory nociception.

Authors:  Dimitris N Xanthos; Simon Gaderer; Ruth Drdla; Erin Nuro; Anastasia Abramova; Wilfried Ellmeier; Jürgen Sandkühler
Journal:  Mol Pain       Date:  2011-06-03       Impact factor: 3.395

Review 8.  Mast cell mediation of visceral sensation and permeability in irritable bowel syndrome.

Authors:  William L Hasler; Gintautas Grabauskas; Prashant Singh; Chung Owyang
Journal:  Neurogastroenterol Motil       Date:  2022-03-21       Impact factor: 3.960

9.  The antinociception of oxytocin on colonic hypersensitivity in rats was mediated by inhibition of mast cell degranulation via Ca(2+)-NOS pathway.

Authors:  Liping Gong; Jing Li; Yan Tang; Ting Han; Chuanfei Wei; Xiao Yu; Jingxin Li; Rong Wang; Xuelian Ma; Kejing Liu; Lingyun Geng; Shaozhuang Liu; Bing Yan; Chuanyong Liu
Journal:  Sci Rep       Date:  2016-08-19       Impact factor: 4.379

10.  Regional Differences in Chronic Stress-induced Alterations in Mast Cell and Protease-activated Receptor-2-positive Cell Numbers in the Colon of Ws/Ws Rats.

Authors:  Yong Sung Kim; Moon Young Lee; Han Seung Ryu; Eul-Sig Choi; Jung Taek Oh; Ki Jung Yun; Suck Chei Choi
Journal:  J Neurogastroenterol Motil       Date:  2013-12-30       Impact factor: 4.924

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.